Holen Sie sich die Stockscreener-App
16.79
11.19%
1.69
Handel nachbörslich:
16.79
Schlusskurs vom Vortag:
$15.10
Offen:
$15.3
24-Stunden-Volumen:
362.41K
Relative Volume:
2.15
Marktkapitalisierung:
$1.13B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.13M
KGV:
-20.67
EPS:
-0.8123
Netto-Cashflow:
$-34.10M
1W Leistung:
+9.45%
1M Leistung:
+4.74%
6M Leistung:
-21.58%
1J Leistung:
-0.71%
1-Tages-Spanne:
$15.19
$17.06
1-Wochen-Bereich:
$14.46
$17.06
52-Wochen-Spanne:
$13.77
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie PLSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
16.79 | 1.02B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences at Canaccord Conference: Strategic Expansion in Ablation By Investing.com - Investing.com Canada
Smart tools for monitoring Pulse Biosciences Inc.’s price actionBuy Signal & Expert Curated Trade Ideas - Newser
Is it time to cut losses on Pulse Biosciences Inc.Long Setup & Real-Time Chart Breakout Alerts - Newser
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2025 Earnings Call Transcript - Insider Monkey
Price action breakdown for Pulse Biosciences Inc.Forecast Cut & AI Driven Stock Movement Reports - Newser
Pulse Biosciences Cash Jumps in Q2 - AOL.com
Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - uk.finance.yahoo.com
Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: N - GuruFocus
Pulse Biosciences Reports Q2 2025 Progress and Results - TipRanks
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences' Q2 2025: Unraveling Contradictions in Partnerships, R&D, and Clinical Strategies - AInvest
Pulse Biosciences Q2 2025 Earnings Call Transcript - MarketBeat
Pulse Biosciences outlines initial percutaneous electrode revenue and IDE milestones while expanding nsPFA clinical programs - MSN
Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results - BioSpace
How moving averages guide Pulse Biosciences Inc. tradingAI Generated Buy/Sell Signal Forecast - Newser
Short interest data insights for Pulse Biosciences Inc.Free High Yield Stock Screening Results - Newser
Pulse Biosciences Reports Q2 2025 Earnings, Outlines Percutaneous Electrode Revenue and IDE Milestones - AInvest
Evaluating Pulse Biosciences (PLSE) as a Speculative Play on Clinical Catalysts in nsPFA Technology - AInvest
Earnings call transcript: Pulse Biosciences Q2 2025 results show increased costs - Investing.com India
Transcript : Pulse Biosciences, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Pulse Biosciences Q2 Loss Widens - MarketScreener
PULSE BIOSCIENCES Earnings Results: $PLSE Reports Quarterly Earnings - Quiver Quantitative
Pulse Biosciences Misses Q2 EPS Estimate by $0.02, Cash at $106.3M as of June 30. - AInvest
Can Pulse Biosciences Inc. be the next market leaderReal Profit Trade Tracker - newsyoung.net
Pulse Biosciences Inc. recovery potential after sell offTechnical Screener for High Growth Stocks - Newser
Best data tools to analyze Pulse Biosciences Inc. stockFree High Return Stock Focus With Safety - Newser
What to expect from Pulse Biosciences Inc. in the next 30 daysEquity Forecast with Predictive AI Screener - Newser
What Fibonacci levels say about Pulse Biosciences Inc. reboundAI-Based Signal Detection for Active Traders - Newser
Order flow analysis tools used on Pulse Biosciences Inc.Volume Confirmed Setup with Entry Confidence - Newser
Published on: 2025-08-13 00:39:39 - Newser
What high frequency data says about Pulse Biosciences Inc.Strong Buy Opportunity with Volume Support - Newser
Chart based analysis of Pulse Biosciences Inc. trendsHigh Yield Watchlist with Filtered Picks - Newser
Using flow based indicators on Pulse Biosciences Inc.Short Term Momentum Based Trading Strategy - Newser
Pulse Biosciences PLSE 2025Q2 Earnings Preview Upside Ahead on Innovative Product Launch - AInvest
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Detecting price anomalies in Pulse Biosciences Inc. with AIFree Real Market Momentum Signal Generator - Newser
Volume spikes in Pulse Biosciences Inc. stock – what they meanCapital Growth Summary Over Five Years - Newser
Pulse Biosciences Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView
Published on: 2025-08-08 04:37:29 - Newser
Pulse Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveFree Trade Scanner With Buy Zone Alerts - Newser
Competitive Positioning of Pulse Biosciences Inc.: Is It Leading or LaggingAI Trend Detection for Entry Timing - Newser
Using Python tools to backtest Pulse Biosciences Inc. strategiesShort-Term Market Movement Forecast Report - Newser
Applying Wyckoff theory to Pulse Biosciences Inc. stockReal-Time Investment Picks with Accuracy - Newser
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):